MediXall Group, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 0.065535 million compared to USD 0.020766 million a year ago. Net loss was USD 0.908067 million compared to USD 1.08 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago. Diluted loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.
For the nine months, sales was USD 0.214925 million compared to USD 0.039025 million a year ago. Net loss was USD 3.11 million compared to USD 5.05 million a year ago. Basic loss per share from continuing operations was USD 0.03 compared to USD 0.05 a year ago. Diluted loss per share from continuing operations was USD 0.03 compared to USD 0.05 a year ago.